DK0662837T3 - Anvendelse af IL-10 til forhindring af insulinafhængig diabetes mellitus - Google Patents

Anvendelse af IL-10 til forhindring af insulinafhængig diabetes mellitus

Info

Publication number
DK0662837T3
DK0662837T3 DK93922725T DK93922725T DK0662837T3 DK 0662837 T3 DK0662837 T3 DK 0662837T3 DK 93922725 T DK93922725 T DK 93922725T DK 93922725 T DK93922725 T DK 93922725T DK 0662837 T3 DK0662837 T3 DK 0662837T3
Authority
DK
Denmark
Prior art keywords
diabetes mellitus
dependent diabetes
prevent insulin
insulin
prevent
Prior art date
Application number
DK93922725T
Other languages
Danish (da)
English (en)
Inventor
Martha W Bond
Kenneth Pennline
Paul J M Vieira
Kevin W Moore
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0662837T3 publication Critical patent/DK0662837T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK93922725T 1992-10-01 1993-09-28 Anvendelse af IL-10 til forhindring af insulinafhængig diabetes mellitus DK0662837T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95552392A 1992-10-01 1992-10-01
PCT/US1993/009030 WO1994008606A1 (en) 1992-10-01 1993-09-28 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus

Publications (1)

Publication Number Publication Date
DK0662837T3 true DK0662837T3 (da) 1999-11-08

Family

ID=25496932

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93922725T DK0662837T3 (da) 1992-10-01 1993-09-28 Anvendelse af IL-10 til forhindring af insulinafhængig diabetes mellitus

Country Status (24)

Country Link
EP (1) EP0662837B1 (sv)
JP (1) JP2739770B2 (sv)
KR (1) KR0166663B1 (sv)
CN (1) CN1093598A (sv)
AT (1) ATE180168T1 (sv)
AU (1) AU689448B2 (sv)
CA (1) CA2145863A1 (sv)
CZ (1) CZ286866B6 (sv)
DE (1) DE69325029T2 (sv)
DK (1) DK0662837T3 (sv)
ES (1) ES2131122T3 (sv)
FI (1) FI951511A (sv)
GR (1) GR3030269T3 (sv)
HK (1) HK1008812A1 (sv)
HU (1) HU217871B (sv)
IL (1) IL107153A (sv)
MX (1) MX9306043A (sv)
MY (1) MY111543A (sv)
NO (1) NO951240L (sv)
SG (1) SG48733A1 (sv)
SK (1) SK281806B6 (sv)
TW (1) TW336172B (sv)
WO (1) WO1994008606A1 (sv)
ZA (1) ZA937244B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0752879A4 (en) * 1994-04-08 1999-07-21 Brigham & Womens Hospital TREATMENT OF AUTOIMMUNE DISEASES WITH TOLERANCE INDUCING AGENTS AND / OR ORAL TH2-ENHANCING CYTOKINES
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
JPH11501506A (ja) * 1994-12-12 1999-02-09 ベス イスラエル デアコネス メディカル センター キメラ型サイトカインおよびその利用
WO1997005895A1 (en) * 1995-08-07 1997-02-20 Schering Corporation Treatment of ocular inflammatory conditions with interleukin-10
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
EP0845994A1 (en) * 1995-08-09 1998-06-10 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US5939069A (en) 1996-08-23 1999-08-17 University Of Florida Materials and methods for detection and treatment of immune system dysfunctions
US6171856B1 (en) 1997-07-30 2001-01-09 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
WO1999006059A2 (en) * 1997-07-30 1999-02-11 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
WO1999019301A1 (fr) * 1997-10-14 1999-04-22 Yoshitomi Pharmaceutical Industries, Ltd. Composes de piperazine et utilisation medicale desdits composes
JP2002289768A (ja) 2000-07-17 2002-10-04 Rohm Co Ltd 半導体装置およびその製法
CN100515491C (zh) * 2005-01-04 2009-07-22 健能隆医药技术（上海）有限公司 白介素-22的医药用途
EP2937088B1 (en) 2012-12-21 2020-11-18 Tokushima University Composition having tissue repairing activity and utilization thereof
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
WO2017181143A1 (en) 2016-04-15 2017-10-19 Generon (Shanghai) Corporation, Ltd. Use of il-22 in treating necrotizing enterocolitis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
ES2131122T3 (es) 1999-07-16
AU689448B2 (en) 1998-04-02
TW336172B (en) 1998-07-11
AU5163593A (en) 1994-05-09
SG48733A1 (en) 1998-05-18
KR0166663B1 (en) 1999-01-15
CA2145863A1 (en) 1994-04-28
KR950703353A (ko) 1995-09-20
HU217871B (hu) 2000-04-28
SK281806B6 (sk) 2001-08-06
DE69325029T2 (de) 1999-10-07
IL107153A0 (en) 1993-12-28
MY111543A (en) 2000-08-30
IL107153A (en) 2000-07-16
NO951240D0 (no) 1995-03-30
FI951511A0 (sv) 1995-03-30
CZ80495A3 (en) 1996-01-17
JPH07507567A (ja) 1995-08-24
ATE180168T1 (de) 1999-06-15
GR3030269T3 (en) 1999-08-31
ZA937244B (en) 1994-06-27
FI951511A (sv) 1995-03-30
HU9500933D0 (en) 1995-05-29
JP2739770B2 (ja) 1998-04-15
CZ286866B6 (en) 2000-07-12
HUT71421A (en) 1995-11-28
EP0662837A1 (en) 1995-07-19
WO1994008606A1 (en) 1994-04-28
HK1008812A1 (en) 1999-05-21
NO951240L (no) 1995-05-30
MX9306043A (es) 1994-04-29
CN1093598A (zh) 1994-10-19
DE69325029D1 (de) 1999-06-24
EP0662837B1 (en) 1999-05-19
SK42395A3 (en) 1997-01-08

Similar Documents

Publication Publication Date Title
DK0662837T3 (da) Anvendelse af IL-10 til forhindring af insulinafhængig diabetes mellitus
ES1014870Y (es) Jeringa de seguridad monouso.
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
DK0467792T3 (da) Fungicid komposition til behandling af udsæd
DE69211406D1 (de) Verwendung von Rapamycin zur Behandlung des Diabetes
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
ES2072784T3 (es) Benzo- y piridopiridonas substituidas con sulfonilbencilo.
DK440288D0 (da) Middel til behandling af diabetes mellitus
DE69114730T2 (de) Flüssigkristallverbindung.
FI894723A0 (fi) Keramisk kropp och foerfarande foer dess framstaellning.
DK0869785T3 (da) 4-Hydroxycoumarin-3-carboxyamider til behandling af ikke-insulinafhængig diabetes mellitus
KR950700738A (ko) 당뇨병 치료를 위한 퀴놀린-3-카르복시아미드 화합물의 용도(the use of quinoline-3-carboxamide compounds for treatment of diabetes)
WO1991008510A3 (en) Organic optical elements and nonlinear optical devices
FR2670081B3 (fr) Structure de support, notamment pour le palissage des vignes et similaires.
DK0720597T3 (da) Triarylethylenderivater til terapeutisk anvendelse
DE69105239D1 (de) Akarizide Zusammensetzung.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
JPS5390262A (en) Imidazolonecarboxamide derivs.
JPS549258A (en) Epidesmosterol derivatives
DE69107543D1 (de) Flüssigkristallverbindung.
JPS53138753A (en) Display device
DE69107357D1 (de) Flüssigkristallzusammensetzungen.
JPS53132541A (en) Optically active 2-alkyl-4-isopropenyl cyclohexanone and its preparation
IT7823474A0 (it) Impianto per l'applicazione di laminati.
ES1023361Y (es) Jeringuilla de seguridad.